Workshops Day Two
workshops day two
Professor Peter Selby
Consultant Endocrinologist, Manchester Royal Infirmary
- Not available at this time
- Not available at this time
- Not available at this time
Not available at this time
Professor Tash Masud
Professor in Musculoskeletal Gerontology, Nottingham University Hospitals NHS Trust, Nottingham, UK
Gait and balance: Hall 6b
- How do I screen for a gait and balance disorder?
- How do I use gait and balance assessment to help make a diagnosis?
- How do I incorporate gait and balance assessments into a busy osteoporosis clinic?
Examination of gait and balance are essential components of assessing falls risk and are therefore very relevant to the holistic approach to fracture prevention. Clinicians of all disciplines in busy clinics sometimes tend to neglect this important area. This workshop will teach a structured, quick and easy-to-use approach to assessing gait and balance. This will aid diagnosis of gait and balance disorders, which will help in further management of the patient in reducing fractures.
Dr Jennifer Walsh
Senior Clinical Lecturer, University of Sheffield
Osteoporosis in young adults: Hall 10a
- At what level of BMD should I be concerned about a young adult?
- What investigations should I do in a young adult with low BMD?
- It is ever appropriate to use osteoporosis medication in young adults?
Young adults may present to metabolic bone clinics because they have risk factors for low bone density (such as inflammatory disease or low body weight) or because they have had unusual fractures. This workshop will review how to identify possible underlying contributors to low bone density through history and investigation. We will discuss how to address treatable causes and modifiable risk factors, and the uncommon situations where pharmacological treatment might be considered.
Dr Sanjeev Patel
Consultant Physician and Rheumatologist at St Helier Hospital, Senior lecturer in Rheumatology at St Georges Hospital Medical School, London
Clinical Conundrums including complications of treatment: Hall 11b
- How is fracture risk defined and how can osteoporosis treatment thresholds be used?
- How do secondary causes of osteoporosis (such as chronic kidney disease) - affect fracture risk and influence treatment decisions?
- How do potential complications of osteoporosis drug treatment, such as atypical femoral fractures, influence treatment decisions, and how are such complications managed?
This workshop presents practical issues in osteoporosis management using a case-based discussion format. The convenors will present cases to the audience for review and comment prior to a discussion on the actual management and outcomes. The focus will be on making decisions on when to treat, managing secondary causes of osteoporosis, and complications of osteoporosis treatment.
Clinical Specialist Physiotherapist in Falls and Osteoporosis
Physical activity for bone health - What works and what's safe?: Executive One
- What type of exercise is most osteogenic?
- What types of exercise should I avoid?
- What are the aims of exercise for people with osteoporosis?
Physical activity is a key component in the maintenance of good bone health. However, exercise is often overlooked in patients with osteoporosis due to fears of causing pain or even a fracture. The aim of the workshop is to present evidence-based exercise interventions for individuals with known low BMD (with or without the presence of fracture) and to consider the role of physical activity in promoting bone health throughout the life-course. Not
Dr Nicola Crabtree
Principle Clinical Scientist in Bone Densitometry, Birmingham Children’s Hospital, UK
Bone Densitometry: technical interpretation from the cradle to the grave: Hall 11a
- What is the most important technical limitation when interpreting DXA in children?
- What factors are likely to impact the interpretation of DXA scans in young (
- What technical factors need to be considered when assessing and interpreting older adults?
DXA is the preferred tool for the assessment of bone density and fracture risk in both children and adults. However, the technical considerations when interpreting DXA scans vary throughout the life-course. Issues such as scan site, scan quality and follow up scanning can differ by age and clinical condition. The aim of this workshop is to discuss, using a series of pertinent case studies, the technical challenges faced when interpreting DXA scans.
Professor Juliet Compston
Professor of Bone Medicine, University of Cambridge
When should HRT be used in the prevention and treatment of osteoporosis? : Executive Two
- What patient profile is best suited to the use of HRT to prevent fracture?
- How do age and HRT formulation affect the risk-benefit ratio of HRT in postmenopausal women?
- For how long should HRT be given when used to prevent fracture?
Over the past 25 years, several interventions have been approved for the prevention of fractures in postmenopausal women and have largely replaced the use of HRT for this indication. Recent analyses suggest a more favourable risk-benefit ratio for HRT in younger postmenopausal women than was previously believed. The aim of this workshop is to re-examine the role of HRT in preventing fragility fractures in postmenopausal women at risk of fracture.
Professor Sue Lanham-New
Professor of Human Nutrition, University of Surrey
Optimal nutrition: Hall 6a
- What are currently the best - evidence-based – nutritional strategies for developing and maintaining bone health across the lifecycle?
- What particular nutrients and dietary patterns are detrimental to bone health during the lifecourse?
Nutrition is a modifiable (exogenous) factor that can have a very positive effect on bone health – during growth and development as well as in maintaining bone integrity during the ageing process. The aim of the workshop is to give a detailed, evidence-based outline of key optimal nutritional strategies for improving bone health during the lifecycle and to discuss those nutrients and dietary patterns that should be minimised or avoided for skeletal health.